PHYSICIAN AND PATIENT PERCEPTIONS REGARDING CARE TRANSITIONS, ORAL ANTICOAGULANT TREATMENT AND MANAGEMENT OF NON-VALVULAR ATRIAL FIBRILLATION

被引：0
|
作者：
Stephenson, J. [1 ]
Franchino-Elder, J. [2 ]
Zhang, X. [1 ]
Tan, H. [3 ]
Kraft, E. [4 ]
Wang, C. [2 ]
Willey, V [1 ]
机构：
[1] HealthCore Inc, Wilmington, DE USA
[2] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[3] HealthCore Inc, San Diego, CA USA
[4] Anthem, Denver, CO USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.520
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV84
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [1] Patient with non-valvular atrial fibrillation on ineffective anticoagulant therapy
    Kot, Anna
    Starzyk, Katarzyna
    Dobaj, Lukasz
    Bakowski, Dawid
    Wozakowska-Kaplon, Beata
    KARDIOLOGIA POLSKA, 2016, 74 : 52 - 54
  • [2] The management of anticoagulant treatment in non-valvular atrial fibrillation real-world patients
    Valeriani, Emanuele
    Ageno, Walter
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 62 : 7 - 8
  • [3] Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF)
    Masseria, C.
    Lin, I.
    Mardekian, J.
    Frean, M.
    Phatak, H.
    Kamble, S.
    Unniachan, S.
    Petkun, W.
    Abdulsattar, Y.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1084 - 1084
  • [4] Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
    Xiong, Qinmei
    Shantsila, Alena
    Li, Juxiang
    Hong, Kui
    Lip, Gregory Y. H.
    ARCHIVES OF MEDICAL SCIENCE, 2016, 12 (01) : 216 - 218
  • [5] Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study
    Ramagopalan, Sreeram, V
    Stamp, Elaine
    Sammon, Cormac J.
    Besford, Megan
    Carroll, Robert
    Mehmud, Faisal
    Alikhan, Raza
    FUTURE CARDIOLOGY, 2019, 15 (04) : 301 - 309
  • [6] Variability in the benefit of the novel oral anticoagulant agents in patients with non-valvular atrial fibrillation
    Giuseppe Patti
    Ilaria Cavallari
    Internal and Emergency Medicine, 2015, 10 : 395 - 396
  • [7] Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
    Calderon, Jose Miguel
    Martinez, Fernando
    Diaz, Javier
    Fernandez, Antonio
    Sauri, Inmaculada
    Uso, Ruth
    Trillo, Jose Luis
    Vela, Sara
    Bea, Carlos
    Redon, Josep
    Forner, Maria Jose
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [8] Reasons for discontinuation of direct oral anticoagulant therapy in patients with non-valvular atrial fibrillation
    Renner, Elizabeth
    Mouland, Erin
    Saad, Samira
    Ha, Nghi
    Kim, Pauline
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 617 - 618
  • [9] Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation
    Mehmet Agirbasli
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 570 - 570
  • [10] Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China
    Xiang, Xiao
    Cao, Yaying
    Sun, Kexin
    Song, Jing
    Tian, Yaohua
    Yin, Qiongzhou
    Juan, Juan
    Hu, Yonghua
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 255 - 261
12345